The present study also suggested that the senescence of AECs may be a profibrotic initiator in IPF and that the PTEN/Akt pathway may be a new candidate for senolytic drugs, which may advance treatment of IPF. This evidence concerns the gene AKT1 and idiopathic pulmonary fibrosis.